A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Clinical trial NCT03556202 · TERMINATED
Trial details
- NCT number
- NCT03556202
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-03
- Primary completion
- 2022-02-07
- Enrollment
- 1936
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.